What’s new in primary ITP? Key updates from ASH 2024

touchPODCAST

Player FM - Internet Radio Done Right

הוסף לפני three שנים

תוכן מסופק על ידי touchpodcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי touchpodcast או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

The Sarah Fraser Show

1
SISTER WIVES: The Brown Family Plans Garrison's Funeral, Gives NEW Details About His Passing. Justin Baldoni v Blake Lively UPDATES, First Pictures Of Micah Plath’s Broken Nose Have Surfaced!… 36:16

לפני 18 ימים36:16

הפעל מאוחר יותר

רשימות

לייק

אהבתי

36:16

DANMMMMM…Have I got a show for you! First, a lot of Sister Wives tea - new rumors have surfaced Janelle Brown is leaving the show. Plus, Gabe Brown gives a life update after losing and tragically finding his brother Garrison dead. Sadly, Garrison took his own life in March 2024. Then we head over to discuss the new Welcome To Plathville tea. The first pictures of Micah Plath have surfaced after being beat up by his brother Issac and it doesn’t look good for the future of his modeling career. Lastly, we discuss the latest in the Justin Baldoni v Blake Lively case, Justin is back on social media and it was the perfect social media return. Timestamps: 00:00:00 - Open and new Sister Wives news 00:05:43 - Janelle Brown leaving the show? Sister Wives Closet is officially closed 00:12:45 - A new pic of Micah Plath’s broken nose has surfaced 00:18:18 - Justin Baldoni back on social media and Taylor Swifts team is pissed at Justin Baldoni MY Go Big Podcasting Courses Are Here! Purchase Go Big Podcasting and learn to start, monetize, and grow your own podcast. USE CODE: MOM15 for 15% OFF (code expires May 11th, 2025) **SHOP my Amazon Marketplace - especially if you're looking to get geared-up to start your own Podcast!!!** https://www.amazon.com/shop/thesarahfrasershow Show is sponsored by: Download Cash App & sign up! Use our exclusive referral code TSFS in your profile, send $5 to a friend within 14 days, and you’ll get $10 dropped right into your account. Terms apply Horizonfibroids.com get rid of those nasty fibroids Gopurebeauty.com science backed skincare from head to toe, use code TSFS at checkout for 25% OFF your order Nutrafol.com use code TSFS for FREE shipping and $10 off your subscription Rula.com/tsfs to get started today. That’s R-U-L-A dot com slash tsfs for convenient therapy that’s covered by insurance. SkylightCal.com/tsfs for $30 OFF your 15 inch calendar Quince.com/tsfs for FREE shipping on your order and 365 day returns Warbyparker.com/tsfs make an appointment at one of their 270 store locations and head to the website to try on endless pairs of glasses virtually and buy your perfect pair Follow me on Instagram/Tiktok: @thesarahfrasershow ***Visit our Sub-Reddit: reddit.com/r/thesarahfrasershow for ALL things The Sarah Fraser Show!!!*** Advertise on The Sarah Fraser Show: thesarahfrasershow@gmail.com Got a juicy gossip TIP from your favorite TLC or Bravo show? Email: thesarahfrasershow@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices…

לפני שנה 40:35

MP3•בית הפרקים

touchPANEL DISCUSSION for touchONCOLOGY

Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.

The experts

Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Sanofi.

This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

102 פרקים

#Science #TouchPODCAST

What’s new in primary ITP? Key updates from ASH 2024

touchPODCAST

published לפני שנה

שתפו

MP3•בית הפרקים

touchPANEL DISCUSSION for touchONCOLOGY

The experts

Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Sanofi.

This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

102 פרקים

#Science #TouchPODCAST

כל הפרקים

touchPODCAST

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

לפני 17 ימים14:36

14:36

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com…

touchPODCAST

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

לפני 17 ימים14:36

14:36

touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchrespiratory.com…

touchPODCAST

1
Advances in dry eye disease: From diagnosis to new treatment targets 37:43

לפני 24 ימים37:43

37:43

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today. The expert Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from A lcon Vision, LLC. The activity is jointly provided by USF Health and touchIME. For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/…

touchPODCAST

1
Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus 35:33

לפני 25 ימים35:33

35:33

touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monitoring treatment outcomes and evaluating effectiveness of therapy in clinical practice. The experts Prof. Giuseppe Querques, IRCCS Hospital San Raffaele, Milan, Italy Dr Arshad M. Khanani, Sierra Eye Associates, Reno, NV, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Astellas Pharma Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchophthalmologyime.org/…

touchPODCAST

1
The potential of BTKi therapies in delaying MS progression 13:32

לפני 4 weeks13:32

13:32

touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalban also considers current guideline-recommended therapies for progressive MS and highlights key areas of remaining unmet treatment need. The expert Prof. Xavier Montalban, Centre d'Esclerosi Múltiple de Catalunya (Cemcat) and Vall d'Hebron University Hospital, Barcelona, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is provided by an independent medical education grant from Sanofi. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchneurology.com/…

touchPODCAST

1
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors 30:27

לפני 5 weeks30:27

30:27

touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthenia gravis can be used to inform treatment decisions, the latest clinical data for FcRn inhibitors and the best practice strategies for using FcRn inhibitors in clinical practice. The experts Prof. Michael Nicolle – Western University and London Health Sciences Centre, London, ON, Canada Dr Karissa Gable – Duke University, Durham, NC, USA Ms Missy Pittman – Duke University, Durham, NC, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Argenx and UCB, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/reducing-burden-of-disease-in-gmg-exploring-the-role-of-fcrn-inhibitors/…

touchPODCAST

1
MDT perspectives on why and how to implement continuous glucose monitoring in T2D 13:26

לפני 5 weeks13:26

13:26

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Nurse specialist: Ms. Lori Berard Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
MDT perspectives on evolving options for insulin therapy 10:05

לפני 5 weeks10:05

10:05

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
MDT perspectives on understanding clinical inertia in T2D 12:14

לפני 5 weeks12:14

12:14

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

לפני 5 weeks55:41

55:41

touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

לפני 5 weeks55:41

55:41

touchSYMPOSIUM for touchRESPIRATORY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY 33:43

לפני 7 weeks33:43

33:43

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchneurologyime.org/…

touchPODCAST

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY 33:45

לפני 7 weeks33:45

33:45

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchendocrinologyime.org/…

touchPODCAST

1
The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy 38:58

לפני 8 weeks38:58

38:58

touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms. The experts Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia 35:35

לפני 8 weeks35:35

35:35

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France Prof. Alessandro Vannucchi – University of Florence, Florence, Italy This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/…

ברוכים הבאים אל Player FM!

Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.